Table 1.
Age (years) | Prevalence of eGFR < 60 mL/min/1.73 m2 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
>75 (the studied population) | 75–79 | 80–84 | 85–89 | >90 | ||||||
% | 95% CI | % | 95% CI | % | 95% CI | % | 95% CI | % | 95% CI | |
F + M | 26.9 | 23.1–30.9 | 24.2 | 20.2–28.7 | 29.4 | 23.2–36.5 | 30.4 | 21.5–41.2 | 37.2 | 9.7–76.5 |
F | 32.0 | 27.7–36.7 | 29.6 | 24.6–35.1 | 34.1 | 26.5–42.6 | 35.3 | 23.0–49.8 | ||
M | 15.8 | 10.4–23.4 | 14.4 | 8.2–24.0 | 15.2 | 8.4–26.2 | 21.2 | 11.5–35.8 | 31.4 | 5.7–77.5 |
WOBASZ Senior: general population of the study: 918 (F 452, M 466), CKD population: 196 (F 129, M 67), age ≥75, MDRD4 eGFR (mL/min/1.73 m2)
F female, M male